A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis. (Q35208555)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

Anan S Raghunath

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Jonathan R B Green

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

2088-2101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

Treatment of gastro-oesophageal reflux disease in adults

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Evidence based medicine: what it is and what it isn't

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Meta-analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Evidence for therapeutic equivalence of lansoprazole 30mg and esomeprazole 40mg in the treatment of erosive oesophagitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Strategies for reducing the prescribing of proton pump inhibitors (PPIs): patient self-regulation of treatment may be an under-exploited resource

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Epidemiology of reflux disease and reflux esophagitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

ABC of the upper gastrointestinal tract: Oesophagus: heartburn

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2803%2980207-2

7 January 2021

10.1016/S0149-2918(03)80207-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12946553%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference